Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | PTGX | TERN | ||
| Company | Arena Pharmaceuticals | Protagonist Therapeutics Inc | Terns Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 99.97 | 101.59 | 52.76 | ||
| High | 100.00 | 104.31 | 52.77 | ||
| Low | 99.97 | 101.59 | 52.65 | ||
| Latest | 99.99 | 103.78 | 52.72 | ||
| Change | +0.06 | +0.11 | -0.07 | ||
| % Change | +0.06% | +0.11% | -0.13% | ||
| Volume | 5,718,500 | 601,600 | 10,851,300 | ||
| 20-Day Average Volume | 1,676,465 | 976,950 | 9,258,375 | ||
| Previous Close | 99.93 | 103.67 | 52.79 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 98.94 | 48.87 | ||
| 20-Day Raw Stochastic | 99.86% | 79.72% | 96.37% | ||
| 20-Day Relative Strength | 75.07 | 61.64 | 72.46 | ||
| Weighted Alpha | -14.40 | +110.59 | +819.99 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | +1.58% since 03/26/26 | -0.85% since 03/26/26 | ||
| Low | 93.54 on 03/07/22 | 97.89 on 03/27/26 | 52.65 on 04/02/26 | ||
| High | 100.00 on 03/10/22 | 107.84 on 04/01/26 | 53.08 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | +10.12% since 03/02/26 | +25.43% since 03/02/26 | ||
| Low | 92.85 on 02/22/22 | 87.82 on 03/06/26 | 38.82 on 03/03/26 | ||
| High | 100.00 on 03/10/22 | 107.84 on 04/01/26 | 53.19 on 03/26/26 | ||
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | +19.04% since 01/02/26 | +31.44% since 01/02/26 | ||
| Low | 89.03 on 01/25/22 | 77.00 on 02/23/26 | 33.43 on 01/12/26 | ||
| High | 100.00 on 03/10/22 | 107.84 on 04/01/26 | 53.19 on 03/26/26 | ||
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | +59.71% since 10/02/25 | +556.54% since 10/02/25 | ||
| Low | 48.12 on 12/06/21 | 62.24 on 10/07/25 | 6.99 on 10/22/25 | ||
| High | 100.00 on 03/10/22 | 107.84 on 04/01/26 | 53.19 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 6,622,097 | 6,084,574 | ||
| Shares Outstanding, K | 61,659 | 63,809 | 115,413 | ||
| Annual Sales | 50,000 | 46,020,000 | 0 | ||
| Annual Net Income | -616,430,000 | -130,150,000 | -88,850,000 | ||
| Last Quarter Sales | 50,000 | 7,440,000 | 0 | ||
| Last Quarter Net Income | -155,610,000 | -44,380,000 | -24,640,000 | ||
| 60-Month Beta | 0.55 | 2.12 | -0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | -0.69 on 02/25/26 | -0.27 on 11/10/25 | ||
| Latest Earnings Date | 05/04/22 | 05/05/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||